Jonathan Harry Schatz

26PUBLICATIONS
133CO-AUTHORS
Liquid biopsiesMolecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Sep 18, 2026
RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy Sensitivity.

|Nov 07, 2025
Racial and clinical determinants of response in 2304 large B-cell lymphomas treated with CD19 CAR T in clinical trials.

Soon Jye Kho, Sheila Diamond, Penelope Lafeuille

|Aug 02, 2025
Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline.

Toral Shastri, Asaad Trabolsi, Artavazd Arumov

|Jul 31, 2025
Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy.

Paola Manara, Austin D Newsam, Venu Venkatarame Gowda Saralamma

Pageof 5

Frequent Collaborators

6 joint publications

Francesco Maura

5 joint publications

Asaad Trabolsi

4 joint publications

Ola Landgren

4 joint publications

Artavazd Arumov